Literature DB >> 10787066

Release of endotoxin-binding proteins during major elective surgery: role of soluble CD14 in phagocytic activation.

N Hiki1, D Berger, Y Mimura, J Frick, M A Dentener, W A Buurman, M Seidelmann, M Kaminishi, H G Beger.   

Abstract

Our previous study demonstrated that soluble CD14 (sCD14) modulates the biologic activity of circulating endotoxin, which appears after surgery. In this study, we examined the behavior of endotoxin-binding proteins, such as sCD14, lipopolysaccharide-binding protein (LBP), and bactericidal/permeability-increasing protein (BPI), in patients' plasma after major abdominal surgery and the phagocytic secretion of sCD14 from peripheral blood mononuclear cells (PBMCs) throughout the observation period. In a prospective study, 15 patients undergoing major abdominal surgery (gastrectomy, n = 3; pancreatectomy, n = 10: colectomy, n = 2) were involved in this study. The endotoxin-binding proteins were perioperatively (preoperatively; postoperative hour 6; days 1, 2, 3, 4, 5, 7, and 10) measured by an enzyme-linked immunosorbent assay (ELISA). To exclude the hemodilution effect of samples, each parameter was corrected by dividing the respective value by the albumin concentration. The phagocytic activity at each time point was tested as an ex vivo sCD14 secretion from PBMCs in the presence and absence of exogenously added endotoxin, Escherichia coli 055B5 (1 ng/ml). Significant endotoxemia (0.35 +/- 0.13 EU/ml; p < 0.05) was observed 6 hours after the beginning of surgery. The sCD14/albumin value rapidly increased at 6 hours after surgery, peaked on day 1, and sequentially declined, whereas the BPI/albumin and LBP/albumin ratios increased more gradually and peaked on day 2. The secretion of sCD14 from 2 x 10(6) PBMCs was significantly enhanced from 6 hours after operation. The increased plasma level of sCD14 may be explained by the parallel-enhanced sCD14 PBMC production. Activated secretion of these endotoxin-binding proteins may play a role in regulating the biologic activity of circulating endotoxin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10787066     DOI: 10.1007/s002689910080

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  9 in total

1.  Effects of postoperative enteral immune-enhancing diet on plasma endotoxin level, plasma endotoxin inactivation capacity and clinical outcome.

Authors:  Guoxiang Yao; Xinbo Xue; Xingpei Liu; Jianming Wang; Jiaqin Qian
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

2.  Different effects of a CD14 gene polymorphism on disease outcome in patients with alcoholic liver disease and chronic hepatitis C infection.

Authors:  C Meiler; M Muhlbauer; M Johann; A Hartmann; B Schnabl; N Wodarz; G Schmitz; J Scholmerich; C Hellerbrand
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

3.  Expression of CD14 protein and its gene in liver sinusoidal endothelial cells during endotoxemia.

Authors:  Jian-Ping Gong; Li-Li Dai; Chang-An Liu; Chuan-Xin Wu; Yu-Jun Shi; Sheng-Wei Li; Xu-Hong Li
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

4.  Expression of lipopolysaccharide binding protein and its receptor CD14 in experimental alcoholic liver disease.

Authors:  G Q Zuo; J P Gong; C A Liu; S W Li; X C Wu; K Yang; Y Li
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

5.  Lipopolysaccharide induced synthesis of CD14 proteins and its gene expression in hepatocytes during endotoxemia.

Authors:  Sheng-Wei Li; Jian-Ping Gong; Chuan-Xin Wu; Yu-Jun Shi; Chang-An Liu
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

6.  Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis.

Authors:  Armando Guerra Ruiz; Fernando Casafont; Javier Crespo; Amalia Cayón; Marta Mayorga; Angel Estebanez; José Carlos Fernadez-Escalante; Fernando Pons-Romero
Journal:  Obes Surg       Date:  2007-10       Impact factor: 4.129

7.  Recombinant soluble CD14 reduces severity of intramammary infection by Escherichia coli.

Authors:  Jai-Wei Lee; Max J Paape; Theodore H Elsasser; Xin Zhao
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

8.  Synthesis of endotoxin receptor CD14 protein in Kupffer cells and its role in alcohol-induced liver disease.

Authors:  Li-Li Dai; Jian-Ping Gong; Guo-Qing Zuo; Chuan-Xin Wu; Yu-Jun Shi; Xu-Hong Li; Yong Peng; Wu Deng; Sheng-Wei Li; Chang-An Liu
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

9.  Lipopolysaccharide binding protein and sCD14 are not produced as acute phase proteins in cardiac surgery.

Authors:  Manuela Kudlova; Pavel Kunes; Martina Kolackova; Vladimir Lonsky; Jiri Mandak; Ctirad Andrys; Karolina Jankovicova; Jan Krejsek
Journal:  Mediators Inflamm       Date:  2007       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.